Key Takeaways
- • MSX launches Phase 3 pre-IPO subscription on August 31, 2026, featuring Neuralink and Anduril Industries as anchor assets, expanding tokenized access to private market investments traditionally restricted to accredited investors.
- • Neuralink valued at approximately $44 billion at entry for pre-IPO subscriptions, with minimum investment thresholds lowered to democratize access to flagship AI and defense technology companies.
- • Phase 1 and Phase 2 assets have completed full product cycle validation: CBRS and SPCX successfully listed and traded, while Anthropic and Polymarket have entered premium buyback phases, demonstrating MSX's operational execution model.
- • MSX's tokenized pre-IPO platform reduces traditional barriers to early-stage unicorn exposure, positioning institutional and sophisticated retail investors to capture value recognition windows before public market pricing occurs.
- • The offering targets AI-focused enterprises advancing physical applications of artificial intelligence, reflecting capital market demand for exposure to core equity stakes in companies with validated technology and clarifying business models.
Summary
MSX Maetong opened subscription for Phase 3 of its tokenized pre-IPO offering on August 31, 2026, introducing Neuralink and Anduril Industries as headline assets. This expansion reflects sustained institutional demand for structured access to premium unlisted companies at valuation inflection points. Neuralink entered the offering at approximately $44 billion in valuation, with minimum subscription requirements designed to broaden participation beyond traditional accredited investor gatekeeping.
The Phase 3 launch builds on demonstrated operational validation from earlier tranches. Phase 1, launched March 2, 2026, introduced CBRS and SPCX, both of which have progressed from subscription and holding to listing and active trading. Phase 2 assets—Anthropic and Polymarket—have advanced to premium buyback phases, completing full-cycle product validation and demonstrating the platform's ability to manage the transition from private subscription through secondary markets to exit outcomes.
The strategic rationale centers on capturing value recognition windows where unicorn companies have secured substantial funding and experienced valuation leaps but remain pre-public. This timing window is characterized by validated technology, clarifying business models, and incomplete public market pricing. Both Neuralink and Anduril represent flagship examples of AI-forward enterprises expanding artificial intelligence into physical applications—Neuralink through neural interface technology and Anduril through autonomous defense systems. The concentration reflects MSX's positioning within higher-risk, higher-conviction segments of the unlisted tech ecosystem.
By tokenizing pre-IPO access on blockchain infrastructure, MSX lowers entry barriers and expands the investor base beyond traditional venture capital and private equity channels. This structural innovation addresses persistent global capital market demand for exposure to companies comparable to SpaceX, OpenAI, and Anthropic—entities that secured blockbuster valuations prior to or in preparation for public market entry. The platform's success in completing full product cycles with earlier cohorts provides operational credibility for Phase 3's expanded mandate.
The Phase 3 launch builds on demonstrated operational validation from earlier tranches. Phase 1, launched March 2, 2026, introduced CBRS and SPCX, both of which have progressed from subscription and holding to listing and active trading. Phase 2 assets—Anthropic and Polymarket—have advanced to premium buyback phases, completing full-cycle product validation and demonstrating the platform's ability to manage the transition from private subscription through secondary markets to exit outcomes.
The strategic rationale centers on capturing value recognition windows where unicorn companies have secured substantial funding and experienced valuation leaps but remain pre-public. This timing window is characterized by validated technology, clarifying business models, and incomplete public market pricing. Both Neuralink and Anduril represent flagship examples of AI-forward enterprises expanding artificial intelligence into physical applications—Neuralink through neural interface technology and Anduril through autonomous defense systems. The concentration reflects MSX's positioning within higher-risk, higher-conviction segments of the unlisted tech ecosystem.
By tokenizing pre-IPO access on blockchain infrastructure, MSX lowers entry barriers and expands the investor base beyond traditional venture capital and private equity channels. This structural innovation addresses persistent global capital market demand for exposure to companies comparable to SpaceX, OpenAI, and Anthropic—entities that secured blockbuster valuations prior to or in preparation for public market entry. The platform's success in completing full product cycles with earlier cohorts provides operational credibility for Phase 3's expanded mandate.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.